TY - JOUR
T1 - Atypical presentation of macrophage activation syndrome with extreme D-dimer elevation in juvenile systemic lupus erythematosus
AU - Hikmah, Zahrah
AU - Masturina, Melinda
AU - Endaryanto, Anang
N1 - Publisher Copyright:
© 2025, Amaltea Medical Publishing House. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Macrophage Activation Syndrome (MAS) is a potentially life-threatening complication of juvenile systemic lupus erythematosus (jSLE), an uncommon but severe autoimmune disease in children. This case report presents a 7-year-old child newly diagnosed with jSLE who developed MAS, marked by persistent fever, abdominal pain, rashes, cytopenia, elevated ferritin, hypertriglyceridemia, hypofibrinogenemia, and significantly elevated D-dimer levels. Diagnostic evaluation revealed low complement levels, positive antinuclear antibodies (ANA), and anti-double-stranded DNA (anti-dsDNA), confirming jSLE based on the SLICC classification criteria and MAS according to EULAR/ACR criteria. Intensive therapy, including methylprednisolone, intravenous immunoglobulin, hydroxychloroquine, and anakinra, led to clinical improvement. This case underscores the unique occurrence of MAS in a patient at the initial diagnosis of jSLE, with an exceptionally elevated D-dimer. Clinicians should maintain high vigilance for MAS in pediatric jSLE cases presenting with systemic inflammation and hematologic abnormalities, as prompt recognition and intervention are essential to improve outcomes.
AB - Macrophage Activation Syndrome (MAS) is a potentially life-threatening complication of juvenile systemic lupus erythematosus (jSLE), an uncommon but severe autoimmune disease in children. This case report presents a 7-year-old child newly diagnosed with jSLE who developed MAS, marked by persistent fever, abdominal pain, rashes, cytopenia, elevated ferritin, hypertriglyceridemia, hypofibrinogenemia, and significantly elevated D-dimer levels. Diagnostic evaluation revealed low complement levels, positive antinuclear antibodies (ANA), and anti-double-stranded DNA (anti-dsDNA), confirming jSLE based on the SLICC classification criteria and MAS according to EULAR/ACR criteria. Intensive therapy, including methylprednisolone, intravenous immunoglobulin, hydroxychloroquine, and anakinra, led to clinical improvement. This case underscores the unique occurrence of MAS in a patient at the initial diagnosis of jSLE, with an exceptionally elevated D-dimer. Clinicians should maintain high vigilance for MAS in pediatric jSLE cases presenting with systemic inflammation and hematologic abnormalities, as prompt recognition and intervention are essential to improve outcomes.
KW - juvenile systemic lupus erythematosus
KW - macrophage activation syndrome
KW - pediatric autoimmune disease
UR - http://www.scopus.com/inward/record.url?scp=105005889180&partnerID=8YFLogxK
U2 - 10.37897/RJP.2025.1.6
DO - 10.37897/RJP.2025.1.6
M3 - Article
AN - SCOPUS:105005889180
SN - 1454-0398
VL - 74
SP - 43
EP - 48
JO - Romanian Journal of Pediatrics
JF - Romanian Journal of Pediatrics
IS - 1
ER -